Clinical Trials Browser

Terminated × Multiple Myeloma × sonidegib × Clear all

NCT02254551 2017-02-16

Safety/Efficacy Study of LDE225 (Sonidegib) Plus Bortezomib in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

Phase 2 Terminated

7 enrolled 6 charts

Multiple Myeloma